Skip to main content
Clinical Trials/ACTRN12617001140347
ACTRN12617001140347
Completed
Phase 1

Treatment of Refractory Obsessive-Compulsive Disorder with Nutraceuticals

Prof Jerome Sarris0 sites28 target enrollmentAugust 4, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Treatment-Refractory Obsessive-Compulsive Disorder
Sponsor
Prof Jerome Sarris
Enrollment
28
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 4, 2017
End Date
May 25, 2020
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Prof Jerome Sarris

Eligibility Criteria

Inclusion Criteria

  • \*18\-75 years of age
  • \*Y\-BOCS score of equal to or greater than 16 at time of entry into the study
  • \*Treatment\-Refractory OCD (defined as inadequate response to 1\. at least 3 trials to serotonin\-reuptake inhibitor medications; 2\. an augmentation trial, for example, an antipsychotic medication; 3\. at least 15 sessions of cognitive and/or behavioural therapy with an experienced clinician OR completion of one in\-patient program specific for OCD treatment.
  • \*Stable treatment for the previous 4 weeks (for example, consistent doses of medications used for their OCD, regular appointments with psychologist for behavioural therapy) OR not currently employing treatment for their OCD

Exclusion Criteria

  • \*Diagnosis of bipolar disorder
  • \*Diagnosis of psychotic disorder
  • \*Strong suicidal ideation (defined as Hamilton Depression rating scale, item\-3 score equal to or greater than 3\)
  • \*Diagnosis of alcohol or substance abuse
  • \*Medications with known or suspected interactions with any of the investigated nutrients, to be determined by the medical investigators on a case by case basis
  • \*Allergy to any component of the investigational products
  • \*Serious or unstable medical conditions, to be determined by the medical investigators on a case by case basis
  • \*Gastrointestinal ulcers or renal stones within the last 2 years
  • \*Pregnancy of women currently breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials